Vertex to acquire ViaCyte

Vertex to acquire ViaCyte, with the goal of accelerating its potentially curative VX-880 programmes in Type 1 diabetes. ViaCyte brings tools, technologies and assets with

Read More »

Help define a hypo

By joining this study, you could contribution to greater understanding of how low blood glucose affects our quality of life, an update by Susannah Hickling.

Read More »